BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 34420428)

  • 1. The prognostic impacts of
    An T; Deng L; Wang Y; Yang Z; Chai C; Ouyang J; Lu X; Zhang C
    Future Oncol; 2021 Nov; 17(33):4471-4479. PubMed ID: 34420428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer.
    Chen JS; Wang YF; Zhang XQ; Lv JM; Li Y; Liu XX; Xu TP
    Neoplasma; 2016; 63(2):223-30. PubMed ID: 26774144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PABPC1 exerts carcinogenesis in gastric carcinoma by targeting miR-34c.
    Zhu J; Ding H; Wang X; Lu Q
    Int J Clin Exp Pathol; 2015; 8(4):3794-802. PubMed ID: 26097561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-regulated Wnt1-inducible signaling pathway protein 1 correlates with poor prognosis and drug resistance by reducing DNA repair in gastric cancer.
    Zhang LH; Wang Y; Fan QQ; Liu YK; Li LH; Qi XW; Mao Y; Hua D
    World J Gastroenterol; 2019 Oct; 25(38):5814-5825. PubMed ID: 31636474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High expression of CD11c indicates favorable prognosis in patients with gastric cancer.
    Wang Y; Xu B; Hu WW; Chen LJ; Wu CP; Lu BF; Shen YP; Jiang JT
    World J Gastroenterol; 2015 Aug; 21(31):9403-12. PubMed ID: 26309367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased expression of prenyl diphosphate synthase subunit 2 correlates with reduced survival of patients with gastric cancer.
    Kanda M; Nomoto S; Oya H; Hashimoto R; Takami H; Shimizu D; Sonohara F; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Murotani K; Fujiwara M; Kodera Y
    J Exp Clin Cancer Res; 2014 Oct; 33(1):88. PubMed ID: 25330808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients.
    Zhang C; Zhang CD; Ma MH; Dai DQ
    World J Gastroenterol; 2018 Mar; 24(11):1206-1215. PubMed ID: 29568201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High Expression of Retinoic Acid Induced 14 (RAI14) in Gastric Cancer and Its Prognostic Value.
    He XY; Zhao J; Chen ZQ; Jin R; Liu CY
    Med Sci Monit; 2018 Apr; 24():2244-2251. PubMed ID: 29654694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KK-LC-1 may be an effective prognostic biomarker for gastric cancer.
    Ji J; Chen J; Wang A; Zhang W; Ju H; Liu Y; Li L
    BMC Cancer; 2021 Mar; 21(1):267. PubMed ID: 33711953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of noggin protein expression in patients with resected gastric cancer.
    Chun SH; Kim EY; Yoon JS; Won HS; Yim K; Hwang HW; Hong SA; Lee M; Lee SL; Kim SS; Sun S; Ko YH
    BMC Cancer; 2021 May; 21(1):558. PubMed ID: 34001012
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Liu LP; Sheng XP; Shuai TK; Zhao YX; Li B; Li YM
    World J Gastroenterol; 2018 Oct; 24(40):4565-4577. PubMed ID: 30386106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KCND2 upregulation might be an independent indicator of poor survival in gastric cancer.
    Wei H; Li Y; Du Y; Ma J
    Future Oncol; 2018 Nov; 14(27):2811-2820. PubMed ID: 30051729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of miR-181d is associated with poor prognosis and tumor progression of gastric cancer.
    Li Z; Guo Q; Lu Y; Tian T
    Cancer Biomark; 2019; 26(3):353-360. PubMed ID: 31524144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Significances of NEDD-9 and FOXL-1 Expression in Intestinal Type Gastric Carcinoma: an Immunohistochemical Study.
    Elaidy NF; Harb OA; Mohamed AM; Hemeda R; Taha HF; Samir A; Elsayed AM; Osman G; Hendawy EIE
    J Gastrointest Cancer; 2021 Jun; 52(2):728-737. PubMed ID: 32794109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FLAD1 is up-regulated in Gastric Cancer and is a potential prediction of prognosis.
    Hu P; Pan Y; Wang C; Zhang W; Huang H; Wang J; Zhang N
    Int J Med Sci; 2020; 17(12):1763-1772. PubMed ID: 32714079
    [No Abstract]   [Full Text] [Related]  

  • 16. Long noncoding RNA HOXA11-AS promotes gastric cancer cell proliferation and invasion
    Liu Y; Zhang YM; Ma FB; Pan SR; Liu BZ
    World J Gastroenterol; 2019 Jun; 25(22):2763-2775. PubMed ID: 31235999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of α5β1-integrin is a prognostic marker for patients with gastric cancer.
    Ren J; Xu S; Guo D; Zhang J; Liu S
    Clin Transl Oncol; 2014 Jul; 16(7):668-74. PubMed ID: 24248895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of Efficacy of Postoperative Chemotherapy by DNA Methylation of CDO1 in Gastric Cancer.
    Harada H; Soeno T; Yokoi K; Nishizawa N; Ushiku H; Hosoda K; Hiki N; Yamashita K
    J Surg Res; 2020 Dec; 256():404-412. PubMed ID: 32777557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CDCA3 is a potential prognostic marker that promotes cell proliferation in gastric cancer.
    Zhang Y; Yin W; Cao W; Chen P; Bian L; Ni Q
    Oncol Rep; 2019 Apr; 41(4):2471-2481. PubMed ID: 30816466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. STRA6 Expression Serves as a Prognostic Biomarker of Gastric Cancer.
    Nakamura S; Kanda M; Shimizu D; Sawaki K; Tanaka C; Hattori N; Hayashi M; Yamada S; Nakayama G; Omae K; Koike M; Kodera Y
    Cancer Genomics Proteomics; 2020; 17(5):509-516. PubMed ID: 32859629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.